Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 2020 Nov 18. pii: S0140-6736(20)32466.
PMID: 33220855

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016